GLS insider filings
GELESIS HOLDINGS, INC. — 21 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-05-03. Screen GLS transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GLS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — GELESIS HOLDINGS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-05-03 | 4 | PureTech Health plc — 10% owner PureTech Health LLC — 10% owner | Purchase (P): 5,000,000 (derivative) @ $5,000,000 · Purchase (P): 2,000,000 (derivative) @ $2,000,000 · Purchase (P): 23,688,047 (derivative) · Purchase (P): 192,307,692 (derivative) | EDGAR |
| 2022-11-22 | 4 | KUCHERLAPATI RAJU S — Director | Purchase (P): 8,000 @ $0.39 · Purchase (P): 92,000 @ $0.45 | EDGAR |
| 2022-06-17 | 4 | KUCHERLAPATI RAJU S — Director | Purchase (P): 24,625 @ $1.95 | EDGAR |
| 2022-06-13 | 4 | Sannino Alessandro — Lead Project Scientist | Disposition to issuer (D): 333,392 (derivative) @ $0 · Grant/award (A): 333,392 (derivative) @ $0 | EDGAR |
| 2022-06-10 | 4 | Chiquette Elaine — Chief Scientific Officer | Grant/award (A): 80,500 · Grant/award (A): 80,500 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Wildman Jane — Director | Grant/award (A): 50,182 | EDGAR |
| 2022-05-09 | 4 | Sannino Alessandro — Lead Project Scientist | Grant/award (A): 68,966 | EDGAR |
| 2022-05-09 | 4 | Perks Dominic — Director | Grant/award (A): 49,270 | EDGAR |
| 2022-05-09 | 4 | Pass David A. — Chief Operating Officer | Grant/award (A): 11,841 · Grant/award (A): 39,922 · Grant/award (A): 431,456 · Grant/award (A): 431,456 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Leider Harry L. — Chief Medical Officer | Grant/award (A): 10,164 · Grant/award (A): 34,266 · Grant/award (A): 269,660 · Grant/award (A): 269,660 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Christopher Clayton — Director | Grant/award (A): 49,270 | EDGAR |
| 2022-05-09 | 4 | Chiquette Elaine — Chief Scientific Officer | Grant/award (A): 34,266 · Grant/award (A): 148,313 · Grant/award (A): 148,313 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Cavanaugh Kathryn — Director | Grant/award (A): 48,814 | EDGAR |
| 2022-05-09 | 4 | FONTEYNE PAUL R. — Director | Grant/award (A): 53,832 | EDGAR |
| 2022-05-09 | 4 | Abraham David — General Counsel | Grant/award (A): 22,732 · Grant/award (A): 233,705 · Grant/award (A): 233,705 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Zohar Yishai — President & CEO, Director | Grant/award (A): 13,157 · Grant/award (A): 48,869 · Grant/award (A): 898,867 · Grant/award (A): 898,867 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Maltz Elliot — Chief Financial Officer | Grant/award (A): 5,082 · Grant/award (A): 31,392 · Grant/award (A): 395,501 · Grant/award (A): 395,501 (derivative) @ $0 | EDGAR |
| 2022-05-09 | 4 | Bauerlein Alison — Director | Grant/award (A): 51,095 | EDGAR |
| 2022-05-09 | 4 | KUCHERLAPATI RAJU S — Director | Grant/award (A): 50,639 | EDGAR |
| 2022-01-19 | 4 | KUCHERLAPATI RAJU S — Director | Purchase (P): 15,000 @ $6.67 | EDGAR |
| 2022-01-18 | 4 | Cavanaugh Kathryn — Director | Option exercise (M): 12,825 · Other (J): 12,825 · Other (J): 12,825 · Other (J): 5,175 (derivative) · Option exercise (M): 12,825 (derivative) | EDGAR |
Recent 8-K events — GELESIS HOLDINGS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-10-31 | 8-K | 1.03 — Bankruptcy or Receivership 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-16 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-09-20 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2023-09-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-08-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-07-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-06-29 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-06-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-05-03 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GLS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs